17-63918839-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000515.5(GH1):c.-63A>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.016 in 1,610,988 control chromosomes in the GnomAD database, including 1,409 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.057 ( 722 hom., cov: 32)
Exomes 𝑓: 0.012 ( 687 hom. )
Consequence
GH1
NM_000515.5 5_prime_UTR
NM_000515.5 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.15
Genes affected
GH1 (HGNC:4261): (growth hormone 1) The protein encoded by this gene is a member of the somatotropin/prolactin family of hormones which play an important role in growth control. The gene, along with four other related genes, is located at the growth hormone locus on chromosome 17 where they are interspersed in the same transcriptional orientation; an arrangement which is thought to have evolved by a series of gene duplications. The five genes share a remarkably high degree of sequence identity. Alternative splicing generates additional isoforms of each of the five growth hormones, leading to further diversity and potential for specialization. This particular family member is expressed in the pituitary but not in placental tissue as is the case for the other four genes in the growth hormone locus. Mutations in or deletions of the gene lead to growth hormone deficiency and short stature. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 17-63918839-T-G is Benign according to our data. Variant chr17-63918839-T-G is described in ClinVar as [Likely_benign]. Clinvar id is 369219.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.177 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GH1 | NM_000515.5 | c.-63A>C | 5_prime_UTR_variant | 1/5 | ENST00000323322.10 | NP_000506.2 | ||
GH1 | NM_022559.4 | c.-63A>C | 5_prime_UTR_variant | 1/5 | NP_072053.1 | |||
GH1 | NM_022560.4 | c.-63A>C | 5_prime_UTR_variant | 1/4 | NP_072054.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GH1 | ENST00000323322.10 | c.-63A>C | 5_prime_UTR_variant | 1/5 | 1 | NM_000515.5 | ENSP00000312673.5 | |||
ENSG00000285947 | ENST00000647774.1 | c.287-333A>C | intron_variant | ENSP00000497443.1 |
Frequencies
GnomAD3 genomes AF: 0.0568 AC: 8611AN: 151644Hom.: 719 Cov.: 32
GnomAD3 genomes
AF:
AC:
8611
AN:
151644
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0118 AC: 17155AN: 1459226Hom.: 687 Cov.: 37 AF XY: 0.0109 AC XY: 7893AN XY: 725990
GnomAD4 exome
AF:
AC:
17155
AN:
1459226
Hom.:
Cov.:
37
AF XY:
AC XY:
7893
AN XY:
725990
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0569 AC: 8634AN: 151762Hom.: 722 Cov.: 32 AF XY: 0.0548 AC XY: 4064AN XY: 74222
GnomAD4 genome
AF:
AC:
8634
AN:
151762
Hom.:
Cov.:
32
AF XY:
AC XY:
4064
AN XY:
74222
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 20, 2021 | - - |
Isolated congenital growth hormone deficiency Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at